DJIA 17,646.57 -37.01 -0.21%
NASDAQ 4,962.93 -29.01 -0.58%
S&P 500 2,067.72 -1.04 -0.05%
market minute promo

AbbVie Inc. (NYSE: ABBV)

68.11 -0.11 (-0.16%)

Quote as of


company name or ticker

Recent Quotes

ABBV $68.09 -0.19%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $68.42
Previous Close $68.22
Daily Range $67.32 - $68.55
52-Week Range $51.37 - $70.76
Market Cap $108.5B
P/E Ratio 60.91
Dividend (Yield) $2.04 (3.0%)
Ex-Dividend Date
Dividend Pay Date
07/13/15
08/14/15
Volume 4,577,388
Average Daily Volume 11,363,429
Current FY EPS $4.27

Sector

Industry

AbbVie Inc. (ABBV) Description

AbbVie Inc. Website: http://www.abbvie.com/

News & Commentary

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

Gilead's (GILD) HCV Drug Harvoni Gets Approval in Japan - Analyst Blog

After Hours Most Active for Jul 6, 2015 : ABBV, INFY, RAD, CAG, GILD, INTC, SFM, SFUN, BNDX, PPC, M

After Hours Most Active for Jul 6, 2015 : ABBV, INFY, RAD, CAG, GILD, INTC, SFM, SFUN, BNDX, PPC, MBI, MU

Premarket Biotech Digest: Arrowhead Initiates Dosing, Vertex Orkambi Approval, Insider Sales

WidePoint Corporation: Does A Samsung Contract Matter With Apple's Dominance In America

The Best Way To Judge Past Performance: Part 2

Premarket Biotech Digest: Geron's Sharp Gain, Bayer Essure AEs, Juno Moves Higher

Premarket Biotech Digest: Celgene-Juno, AbbVie Rx Data, FDA-Gilead Lawsuit

Enanta is growing thanks to collaborations.

Water-Logged And Getting Wetter: AbbVie (ABBV)

See More ABBV News...